Latest News & Features
Big Pharma
Rocket Pharma says Lexeo Therapeutics hired its staff to keep clinical trial programme on track | Employees transferred confidential and proprietary information before leaving the company, it claims. 17 October 2023
Big Pharma
Insulet has been awarded a preliminary injunction against EOFlow on its insulin patch pump products | Dispute and injunction come ahead of Medtronic’s planned $738m acquisition of EOFlow. 12 October 2023
article
New addition brings multi-jurisdiction experience in life sciences and healthcare industries | Significant growth in patent litigation due to complex life sciences disputes and telecom and technology litigation. 12 October 2023
Americas
If the right steps are taken, the US International Trade Commission is an attractive option for firms fearing the loss of their valuable IP, say Mary Prendergast, Mark Whitaker and Nicole Ang of Morrison Foerster. 12 October 2023
Asia
Japanese chemical company accuses Cocrystal of stealing its coQ10 formula for a health supplement | Kaneka says it's willing to sue customers of the accused product as well. 10 October 2023
Big Pharma
Gene-sequencing giant to be punished for defying EC authority by acquiring cancer treatment firm say FT sources | EC concerns over anti-competitive effects could scupper controversial deal. 10 October 2023
Big Pharma
Genexa files lawsuit against KinderFarms relating to agave-based over-the-counter pain relief medicines for children | Accuses KinderFarm of ‘willful, intentional, and deliberate’ actions. 5 October 2023
Biotechnology
Both attorneys have ‘exceptional experience’ in life sciences and previously practised at Dechert. 5 October 2023
Americas
In part 2 of articles assessing the impact of 'Cellect v Samsung', Vincent Shier of Haynes Boone now sets out what the future may hold—both for this unusual case, as well as judicial doctrine in general. 5 October 2023
Big Pharma
Amneal Pharmaceuticals fends off CMP’s US lawsuit alleging infringement of the blood pressure treatment / Dispute centres on whether suspension agents were used in “substantially the same way”. 3 October 2023